Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2013 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Understanding the economic value of molecular diagnostic tests: case studies and lessons learned.
Towse A, Ossa D, Veenstra D, Carlson J, Garrison L. Towse A, et al. Among authors: ossa d. J Pers Med. 2013 Oct 25;3(4):288-305. doi: 10.3390/jpm3040288. J Pers Med. 2013. PMID: 25562729 Free PMC article. Review.
Can and should value-based pricing be applied to molecular diagnostics?
Garau M, Towse A, Garrison L, Housman L, Ossa D. Garau M, et al. Among authors: ossa d. Per Med. 2013 Jan;10(1):61-72. doi: 10.2217/pme.12.99. Per Med. 2013. PMID: 29783475
Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.
Ossa DF, Briggs A, McIntosh E, Cowell W, Littlewood T, Sculpher M. Ossa DF, et al. Pharmacoeconomics. 2007;25(3):223-37. doi: 10.2165/00019053-200725030-00005. Pharmacoeconomics. 2007. PMID: 17335308
Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers?
Ossa DF, Towse A. Ossa DF, et al. Eur J Health Econ. 2004 Jun;5(2):116-21. doi: 10.1007/s10198-003-0213-2. Eur J Health Econ. 2004. PMID: 15452747